WHAT I SEE IN MY PRESCRIPTION

Penn State Health will collect unwanted, unneeded or expired medications, needles and syringes for safe disposal on Saturday, Oct. 26, as part of National Prescription Drug Take-Back Day.

Delaware will hold its 22nd National DEA Prescription Drug Take-Back Day on Saturday, April 30, 2022. Delawareans can discard their expired or unused medications at locations statewide between 10:00 a.m. and 2:00 p.m. There will also be Sharps disposals for needle disposal at select locations, and overdose response education with free Narcan available at select locations.

*Editor/Reporter note: We originally stated that five DEA National Prescription Drug Take Back locations would be offering Overdose Response Training and Narcan distribution to the public; there are only two – Milford and Middletown. We also erroneously stated that there are 23 locations currently participating in the National Prescription Drug Take Back event; there are 22.    […]

The Delaware Division of Public Health (DPH) recently held its 24th Prescription Drug Take-Back Day event. Organized nationally by the Drug Enforcement Administration (DEA), Prescription Drug Take-Back Day is operated locally by DPH. The twice-a-year event (April and October) aims to reduce the risk of prescription medications being diverted for misuse and has resulted in 114,470 pounds of medication being collected in Delaware since 2010. […]

The Delaware Division of Public Health (DPH), in collaboration with the Delaware Division of Professional Regulation (DPR), announces important updates to the Mental Health and Substance Use Disorder section of the My Healthy Community (MHC) Dashboard.  These updates are located within this section’s Prescription Monitoring Program (PMP) tab and present trends in prescription drug dispensing in Delaware. The […]

NEW CASTLE – The Delaware Department of Health and Social Services (DHSS) announced today enhancements to the CostAware website, designed to help Delawareans understand how their health care dollars are spent by comparing the variation of average costs for different episodes of care and medical services based on actual medical and pharmacy claims in Delaware. […]

Amidst a shortage of prescription stimulants, concerns have been raised about the potential increase in illicit drug use. With many individuals relying on prescription stimulants to manage conditions such as attention-deficit/hyperactivity disorder (ADHD), the shortage has left many struggling to access the medication they need. This has led some individuals to turn to illicit drugs […]

Delaware will hold its 25th National DEA Prescription Drug Take-Back Day on Saturday, October 28, 2023. Delawareans can discard their expired or unused medications at locations statewide between 10:00 a.m. and 2:00 p.m. Sharps disposals for needle disposal will be available at select locations, as well as overdose response education with free Narcan available at […]

For Immediate Release: August 13, 2024 Contact: Samuel Barry, Policy Advisor (302) 382-0651, Samuel.Barry@delaware.gov The tracker is a publicly accessible tool for Delawareans to learn about how Prescription Opioid Abatement and Remediation Grants have been distributed to date. Dover, DE – Delaware Auditor of Accounts Lydia E. York published an official Prescription Opioid Settlement Tracker […]

Title: Prescription Sleep Aids a Common Choice for American Insomnia
Category: Health News
Created: 8/29/2013 9:35:00 AM
Last Editorial Review: 8/29/2013 12:00:00 AM

BACKGROUND:Opioids are known to cause respiratory depression, aspiration, and to suppress the immune system. This study aimed to investigate the relationship between short- and long-term opioid use and the occurrence and clinical outcomes of pneumonia in South Korea.METHODS:The data for this population-based retrospective cohort analysis were obtained from the South Korean National Health Insurance Service. The opioid user group consisted of those prescribed opioids in 2016, while the non-user group, who did not receive opioid prescriptions that year, was selected using a 1:1 stratified random sampling method. The opioid users were categorized into short-term (1–89 d) and long-term (≥90 d) users. The primary end point was pneumonia incidence from January 1, 2017–December 31, 2021, with secondary end points including pneumonia-related hospitalizations and mortality rates during the study period.RESULTS:In total, 4,556,606 adults were enrolled (opioid group, 2,070,039). Opioid users had a 3% higher risk of pneumonia and an 11% higher risk of pneumonia requiring hospitalization compared to non-users. Short-term users had a 3% higher risk of pneumonia, and long-term users had a 4% higher risk compared to non-users (P < .001). Additionally, short-term users had an 8% higher risk of hospital-treated pneumonia, and long-term users had a 17% higher risk compared to non-users (P < .001).CONCLUSIONS:Both short- and long-term opioid prescriptions were associated with higher incidences of pneumonia and hospital-treated pneumonia. In addition, long-term opioid prescriptions were linked to higher mortality rates due to pneumonia.

Consultations on the reclassification of two progestogen-only contraceptive pills from prescription-only to pharmacy medicines have been launched.

Experts agree that the incoming Trump administration will likely shake things up in the prescription drug world — most notably when it comes to research and development, drug pricing and PBM reform.

The post What Might the Future of Prescription Drugs Look Like Under Trump? appeared first on MedCity News.

The upcoming U.S. presidential election is stirring discussions around healthcare, especially the cost of prescription drugs and the […]

Eyeglass World launches first retail collection of smart glass technologies in the U.S., including specially designed prescription lens options and hardware for Recon, Vuzix and Epson wearable devices.

Robert J. Bitterman, CEO and President, discusses goals of Cutanea Life Sciences

A nationwide study revealed a significant rise in new prescriptions for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) over the past decade, with a notable increase since 2020.

Highlights: Dr. Basuray challenges the asana misconception, revealing yoga as a comprehensive lifestyle for diabete

Notice issued by medlinkSupreme Court/medlink regarding public interest litigation (PIL) pressing for consequences against doctors neglecting medlinkgeneric prescriptions/medlink.

Pre-exposure prophylaxis (PrEP) with antiretroviral medications is effective in preventing HIV infections. PrEP use has increased between 2013 and 2023.

The IMF’s ‘mediocre’ medium-term outlook merits policy attention

Bimal Jalan delves deep into issues that are critical to the country with suggestions on how to overcome challenges 

Rural Community Health Centres and the new AIIMS have a high staff vacancy; the solution is to manage things efficiently with the resources that are available